CLL Updates and the Venetoclax Story With Matt Davids
Healthcare Unfiltered
Advancements in BCL2 Inhibitors
This chapter explores the progression of BCL2 inhibitors, focusing on the comparison between venetoclax and newer agents like Lasafta Clax and Sunrotoclax. It also discusses the evolution of BTK inhibitors in CLL treatment, highlighting innovations that improve efficacy, safety, and convenience.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
